MERIDIAN, Miss.--(BUSINESS WIRE)-- Vital Care CEO Len Branham today issued the following statement commending members of the Mississippi congressional delegation for championing efforts to prevent a rule change proposed by Centers for Medicare and Medicaid Services (CMS) that threatens the health of chronic care patients in Mississippi and across the country.
“On behalf of the state of Mississippi’s thousands of chronic care patients, I want to applaud Vital Care’s members of Congress for their efforts to halt a CMS rule change that would jeopardize patient access to pain medications used in implanted pain pumps. Rep. Gregg Harper and Sens. Thad Cochran and Roger Wicker were successful in postponing the change to CMS’s payment policy manual that was slated to go into effect on June 29. The change would have prohibited Medicare from reimbursing specialized pharmacies for the pain medications used in implanted pain pumps. Implanted pain pumps have been life changing for many chronic care patients throughout the state of Mississippi and across the United States. Thanks to our congressmen in Washington, CMS has now delayed the change in policy for 45 days. I commend Rep. Harper and Sens. Wicker and Cochran for their efforts and I urge CMS to use this 45 day window to explore the impact that this rule change would have on many the nation’s most vulnerable Medicare beneficiaries.”
About Vital Care:
Vital Care Inc. is a franchise-based network of home infusion therapy providers headquartered in Meridian, Mississippi. Founded 1986, it is one of the largest providers of infusion therapies, operating dozens of locations throughout 18 states.
CONTACT:
Vital Care Inc.
Media Contact:
Emily Flynn, 202-448-5208
[email protected]
KEYWORDS: United States North America District of Columbia Mississippi
INDUSTRY KEYWORDS: Health Public Policy/Government Healthcare Reform Medical Devices Congressional News/Views Pharmaceutical Public Policy State/Local White House/Federal Government Managed Care
MEDIA: